ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with ...

Studies have found a relationship between exposure to elderspeak and behaviors collectively known as resistance to care.

Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of ...

After recent discussions with the DRDC, the research study on Bucillamine is now set to conclude by June 2025, focusing on GABA receptor antibodies and data confirmation for effect size. Positive ...

Projected economic benefits of using AI-powered detection/diagnostic Software as a Medical Device, like eyonis® LCS, will be presented at ISPOR 2025, the annual conference of the leading professional ...

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...

SAN FERNANDO — At least 10 people in the U.S. have been sickened in a listeria outbreak linked to ready-to-eat food products, ...

Medera Inc. ("Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing a range of next-generation therapeutics, today announced that data from ...

Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial PositionPost-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating Joint ...

Is Mitolyn a scam or a legit weight loss solution? Discover the truth from a firsthand user experience, expert analysis, and ...